Samantha Jordan

Pfizer (United States)

Papers

1

Total Citations

7

H-Index

1

About

Dr. Samantha Jordan is a rising leader in the field of drug metabolism and pharmacokinetics, with a focused expertise in developing advanced high-throughput screening technologies. Her major contribution lies in pioneering novel multiplexed assays that enable the rapid, simultaneous evaluation of selective inhibitors for drug-metabolizing enzymes directly within human hepatocytes. This work, exemplified by her 2024 paper "Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes" (7 citations), addresses a critical bottleneck in early-stage drug discovery by providing a more physiologically relevant and efficient method for predicting drug-drug interactions and toxicity. While her citation count is still growing, this foundational methodology is already being adopted by pharmaceutical labs seeking to replace traditional, single-enzyme approaches. Dr. Jordan’s research bridges the gap between cellular biology and translational pharmacology, offering a powerful tool for safer drug design. Her innovative approach to multiplexing marks her as a key contributor to the next generation of ADME (Absorption, Distribution, Metabolism, and Excretion) science.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago